Report Date | |
Manager | |
Fund Name | |
Strategy | |
Latest Return Date | |
Latest Return | |
Latest 6 Months | |
Latest 12 Months | |
Latest 24 Months (pa) | |
Annualised Since Inception | |
Inception Date | |
FUM (millions) | |
Fund Overview | Cyan C3G Fund is based on the investment philosophy which can be defined as a comprehensive, clear and considered process focused on delivering growth. These are identified through stringent filter criteria and a rigorous research process. The Manager uses a proprietary stock filter in order to eliminate a large proportion of investments due to both internal characteristics (such as gearing levels or cash flow) and external characteristics (such as exposure to commodity prices or customer concentration). Typically, the Fund looks for businesses that are one or more of: a) under researched, b) fundamentally undervalued, c) have a catalyst for re-rating. The Manager seeks to achieve this investment outcome by actively managing a portfolio of Australian listed securities. When the opportunity to invest in suitable securities cannot be found, the manager may reduce the level of equities exposure and accumulate a defensive cash position. Whilst it is the company's intention, there is no guarantee that any distributions or returns will be declared, or that if declared, the amount of any returns will remain constant or increase over time. The Fund does not invest in derivatives and does not use debt to leverage the Fund's performance. However, companies in which the Fund invests may be leveraged. |
Manager Comments | The Fund's capacity to outperform in falling markets and its superior downside volatility is demonstrated by its down-capture ratio (since inception) of 58.2% and Sortino ratio (since inception) of 1.27 vs the Index's 0.56. Cyan continued to see heightened levels of corporate activity throughout April and, as a result, they participated in both primary and secondary market capital raisings in companies including Raiz, Alcidion and Maggie Beer. Positive contributors throughout the month included Alcidion, Kelly Group, City Chic, Mighty Craft and Universal Biosensors. Key detractors included Playside, Readcloud, Singular Health, New Zealand Coastal and Zebit. The detractors didn't report any specific negative news about their operations or outlooks and, as such, Cyan believe these declines are temporary. |
More Information |